True Global Ventures 4 Plus (TGV4 Plus) Fund has invested US$8.3 million into Chronicled, a company that focuses on establishing trust and automating transactions between trading partners in the Life Sciences Industry vis-a-vis the MediLedger Network.
The Life Sciences Industry is uniquely complex in how pharmaceutical drugs move from manufacturers to serving patients. Beyond the supply chain there are regulatory requirements, complicated pricing and contracting relationships, and a long list of exceptions to every industry standard for how trading partners do business together.
Blockchain presents an opportunity where the contracts, data, and transactions exchanged between trading partners can be recorded with veracity and verifiable pedigree, which means automation can extend beyond internal systems.
Read the full press release.